Actinium Pharmaceuticals
ATNM
#9120
Rank
$59.89 M
Marketcap
$1.92
Share price
4.95%
Change (1 day)
-60.82%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2024 (TTM): -$46.71 Million USD

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are $0.08 Million USD. In 2023 the company made an earning of -$51.92 Million USD a decrease over its 2022 earnings that were of -$34.11 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$46.71 Million-10.04%
2023 -$51.92 Million52.24%
2022 -$34.11 Million36.61%
2021 -$24.97 Million11.48%
2020 -$22.4 Million1.46%
2019 -$22.08 Million-7.37%
2018 -$23.83 Million-11.46%
2017 -$26.92 Million10.67%
2016 -$24.32 Million15.7%
2015 -$21.02 Million-14.86%
2014 -$24.69 Million129.19%
2013 -$10.78 Million-8.55%
2012 -$11.78 Million
2010 $0 M-152.15%
2009 -$0.02 Million-39.8%
2008 -$0.03 Million120.29%
2007 -$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$37.2 Million-20.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.39 B-938.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$99.84 Million 113.75%๐Ÿ‡บ๐Ÿ‡ธ USA